anxiety
Conditions
Interventions
(2)share of patients into three groups, each containing 20 members, being distributed according to the type of stimulation: motor area M1, dorso-lateral motor cortex and sham (3) the application of te
(4) a reassessment on the last day of tDCS application (10th day)
(5) reassessment with one week after completion of treatment (follow-up 1), (6) re-evaluation at 1 month after completion of treatment.
During the second phase the participants will be randomized thro
Device
Procedure/surgery
E02.331.750
Sponsors
Universidade Federal do Rio Grande do Norte
Universidade Federal de São Paulo
Eligibility
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 75 years; previous medical evaluation with clinical diagnosis of depression, anxiety, chronic pain and pressure lability and being on hemodialysis treatment
Exclusion criteria
Exclusion criteria: Evidence of any cognitive deficit (senile dementia, Alzheimer's); presence of physical and / or organic difficulties; individuals with severe cardiovascular risk or hemodynamically unstable; history of seizures or epileptic disease; pregnancy; metallic implants in the head or neck and cardiac pacemaker.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain improvement verified by a 30% decrease in the visual analog pain scale in patients undergoing hemodialysis with tDCS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression improvement accornding to decrease scores of the Beck depression inventory in patients undergoing hemodialysis with tDCS.;Reduction of the anxiety symptom verified by the reduction of the Hamilton Anxiety Questionnaire in patients undergoing hemodialysis with tDCS.;Functionality improvement verified through the Kidney Disease Quality of Life questionnaire in patients undergoing hemodialysis with tDCS. | — |
Countries
Brazil
Contacts
Public ContactArtur da Silva
Universidade Federal do Rio Grande do Norte
Outcome results
None listed